England Launches Innovative Medicines Fund
The new financing mechanism promises faster access to new treatments, but some industry concerns remain unresolved.
You may also be interested in...
A group of UK academics have broadly welcomed the fund that will pay for innovative non-cancer drugs, but have expressed concern over issues such as the entry criteria and the definition of “high unmet need.” They also say safeguards are needed against possible financial loss to the National Health Service.
England’s Innovative Medicines Fund could make the UK a more attractive launch market following Brexit, but companies must also consider the risks of the fund.
England’s health technology appraisal institute, NICE, has published its real-world evidence framework.